Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Wed, 16.10.2024
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.10.2024
16.10.2024 / 17:47 CET/CEST
in CHF
Performance in %
15.10.2024
MTD
FYTD
CYTD
NAV
249.16
2.0
3.4
[ … ]
Wed, 16.10.2024
Information Services Department
EQS Newswire / 16/10/2024 / 13:00 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 16 October 2024 - John Lee, Chief Executive of the Hong Kong Special Administrative Region today (October 16) announced his third Policy Address entitled "Reform for Enhancing Development and Building Our Future Together", setting out a range of initiatives to [ … ]
Wed, 16.10.2024
cometis AG
GLOBAL ESG MONITOR 2024: ENGINEERING COMPANIES UNDER PRESSURE TO PERFORM: FULL STEAM AHEAD FOR BETTER REPORTING QUALITY
Engineering as the backbone of industrial production and a driver of sustainability: Engineering is crucial for value creation and contributes to achieving the Green Deal goals through sustainable standards. However, the industr [ … ]
Wed, 16.10.2024
Roemer Capital (Europe) Limited
NOT FOR RELEASE, PUBLICATION DISTRIBUTION OR USE, IN WHOLE OR IN PART, BY, IN, INTO FROM OR TO ANY JURISDICTION OR PERSON WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF LAW OR REGULATION
16 October 2024
ROEMER CAPITAL (EUROPE) LIMITED
Invitation to Voluntary Tender
to certain holders of Nebius Group N.V. Class A Ordinary Shares, ISIN: NL00098 [ … ]
Wed, 16.10.2024
Zentiva AG
Zentiva announces voluntary public purchase offer for APONTIS PHARMA – Investment Agreement signed
Zentiva and APONTIS PHARMA signed Investment Agreement
Zentiva will launch voluntary public purchase offer
APONTIS PHARMA shareholders will be offered a cash consideration of EUR 10.00 for each outstanding share of APONTIS PHARMA, crystallizing va [ … ]
Wed, 16.10.2024
APONTIS PHARMA AG
APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer
APONTIS PHARMA and Zentiva signed an investment agreement today
Growth strategy of APONTIS PHARMA to be continued together with Zentiva
APONTIS PHARMA to benefit from the European footprint, the existing research and [ … ]
Wed, 16.10.2024
H&R GmbH & Co. KGaA
Press Release
H&R receives funding approval for climate protection project to reduce CO₂ at Salzbergen site
BMWK funds H&R project for CO₂ reduction at a process furnace in Salzbergen
Funding includes both investment and operating costs for a power-to-heat project
Salzbergen, Germany, October 16, 2024. H&R Chemisch-Pharmazeutische Sp [ … ]
Wed, 16.10.2024
SNP Schneider-Neureither & Partner SE
Corporate News
SNP: Significant Increase of Revenue and Earnings in the Third Quarter – Further Raise of Full-Year Guidance 2024
Order entry increased by 24% to around € 75 million (Q3 2023: € 60.2 million)
Revenue grew by 24% to approximately € 67 million (Q3 2023: € 54.1 million)
Significant improvements in EBIT to around € 8 million (Q3 2023 [ … ]
Wed, 16.10.2024
RIXX Invest AG
EQS-Media / 16.10.2024 / 10:21 CET/CEST
RIXX Invest AG: Rattlesnake Oil & Gas LLC Invests in Sustainable Production Increase
Commissioning of Four Legacy Wells
Expected production increase: 6 to 10 barrels of oil per well/day
Investment volume: USD 200,000 for maintenance and expansion
Berlin, October 16, 2024. RIXX Invest AG announces [ … ]
Wed, 16.10.2024
Straumann Holding AG
Straumann Holding AG
/ Key word(s): 9 Month figures
Invitation: Straumann Group 2024 third-quarter results webcast
16.10.2024 / 10:16 CET/CEST
Date: Tuesday, October 29, 2024
Time: 10:30 – 11:30 a.m. CET
Straumann Group will publish its 2024 third-quarter results on Tuesday, October 29, 2024, at approximately 7: [ … ]